Operating an Overdose Prevention Site Within a Temporary Emergency Shelter During the COVID-19 Pandemic

Overview

Journal Can J Public Health

Publisher Springer Nature

Specialty Public Health

Date 2023 Jul 18

PMID 37462841

Authors

Lexis R Galarneau

Kelsey Speed

Marliss Taylor

Elaine Hyshka

Affiliations

Soon will be listed here.

Abstract

Setting: A temporary emergency shelter was established inside the Commonwealth Stadium in Edmonton, Alberta, to reduce COVID-19 transmission and mitigate health risks among people experiencing homelessness.

Intervention: A non-profit organization, Boyle Street Community Services, opened an overdose prevention site (OPS) between February and March 2022 inside the temporary emergency shelter. People accessed the shelter-based OPS to consume unregulated drugs (via injection, intranasally, or orally), receive medical aid, access sterile drug use equipment, and be connected to additional health and social supports, without leaving the shelter. We conducted short interviewer-administered surveys with OPS participants to examine participant views and identify suggested improvements.

Outcomes: The shelter-based OPS was accessed a total of 1346 times by 174 unique people. Fentanyl was the most common self-reported drug consumed (59%) and most consumption (99% of episodes) was by injection. OPS staff responded to 66 overdoses and reported no deaths. Survey respondents reported that the shelter-based OPS was convenient, with no need to forfeit their shelter spot or find transportation to another OPS. Respondents indicated that the OPS felt safe and accessible and reported that it reduced drug use in other shelter areas. Participants identified the OPS' exclusion of inhalation as a limitation.

Implications: People who use unregulated drugs and are experiencing homelessness are at a higher risk of negative health outcomes, which COVID-19 exacerbated. Integrating temporary shelter/housing and harm reduction services may be an innovative way to lower barriers, increase accessibility, and improve well-being for this structurally vulnerable population. Future operators should consider incorporating inhalation services to further reduce service gaps.

References

Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B . Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014; 145:48-68. DOI: 10.1016/j.drugalcdep.2014.10.012. View

Kennedy M, Karamouzian M, Kerr T . Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review. Curr HIV/AIDS Rep. 2017; 14(5):161-183. DOI: 10.1007/s11904-017-0363-y. View

Wallace B, Barber K, Pauly B . Sheltering risks: Implementation of harm reduction in homeless shelters during an overdose emergency. Int J Drug Policy. 2018; 53:83-89. DOI: 10.1016/j.drugpo.2017.12.011. View

Wang Q, Kaelber D, Xu R, Volkow N . COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2020; 26(1):30-39. PMC: 7488216. DOI: 10.1038/s41380-020-00880-7. View

Taylor H, Leite A, Gautier D, Nunes P, Pires J, Curado A . Community perceptions surrounding Lisbon's first mobile drug consumption room. Dialogues Health. 2024; 1:100031. PMC: 10954018. DOI: 10.1016/j.dialog.2022.100031. View

Wood L, Davies A, Khan Z . COVID-19 precautions: easier said than done when patients are homeless. Med J Aust. 2020; 212(8):384-384.e1. PMC: 7262153. DOI: 10.5694/mja2.50571. View

Schulte M, Hser Y . Substance Use and Associated Health Conditions throughout the Lifespan. Public Health Rev. 2017; 35(2). PMC: 5373082. DOI: 10.1007/BF03391702. View

Richard L, Booth R, Rayner J, Clemens K, Forchuk C, Shariff S . Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: a retrospective cohort study. CMAJ Open. 2021; 9(1):E1-E9. PMC: 7843074. DOI: 10.9778/cmajo.20200287. View

Magwood O, Salvalaggio G, Beder M, Kendall C, Kpade V, Daghmach W . The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use.... PLoS One. 2020; 15(1):e0227298. PMC: 6964917. DOI: 10.1371/journal.pone.0227298. View

10.

Tsai J, Wilson M . COVID-19: a potential public health problem for homeless populations. Lancet Public Health. 2020; 5(4):e186-e187. PMC: 7104053. DOI: 10.1016/S2468-2667(20)30053-0. View

11.

Lew B, Bodkin C, Lennox R, OShea T, Wiwcharuk G, Turner S . The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study. Harm Reduct J. 2022; 19(1):29. PMC: 8935259. DOI: 10.1186/s12954-022-00614-8. View

12.

Russell C, Ali F, Nafeh F, LeBlanc S, Imtiaz S, Elton-Marshall T . A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada. BMC Public Health. 2021; 21(1):2021. PMC: 8571863. DOI: 10.1186/s12889-021-12104-w. View

13.

Galarneau L, Hilburt J, ONeill Z, Buxton J, Scheuermeyer F, Dong K . Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study. PLoS One. 2021; 16(7):e0255396. PMC: 8320992. DOI: 10.1371/journal.pone.0255396. View

14.

Gehring N, Speed K, Launier K, OBrien D, Campbell S, Hyshka E . The state of science on including inhalation within supervised consumption services: A scoping review of academic and grey literature. Int J Drug Policy. 2022; 102:103589. DOI: 10.1016/j.drugpo.2022.103589. View

15.

Fuertes R, Belo E, Merendeiro C, Curado A, Gautier D, Neto A . Lisbon's COVID 19 response: harm reduction interventions for people who use alcohol and other drugs in emergency shelters. Harm Reduct J. 2021; 18(1):13. PMC: 7829636. DOI: 10.1186/s12954-021-00463-x. View